Shanghai United Imaging Healthcare Co., Ltd. (688271.SS) has a MoatMap StockRank of 38/100 based on Quality (63/100), Value (20/100), and Momentum (42/100) factor scores. The current signal is HOLD. Shanghai United Imaging is a high-quality medical equipment manufacturer benefiting from China's aggressive localization policies in high-end healthcare infrastructure. However, its high valuation and geopolitical headwinds limit its near-term global expansion potential.
Shanghai United Imaging Healthcare develops and manufactures high-end medical imaging equipment, including MRI, CT, PET-CT, and digital radiography systems. The company's competitive moat is built on its full-spectrum R&D capabilities, proprietary core components, and high-performance imaging software. It is a dominant market leader in China's medical imaging sector, actively expanding its global footprint to challenge multinational incumbents.
| Price | $16.66 |
| Market Cap | $14.7B |
| P/E (TTM) | 48.86 |
| P/E (Forward) | 30.78 |
| Price/Book | 4.21 |
| Return on Equity | 8.9% |
| Return on Invested Capital | 8.5% |
| Debt/Equity | 7.42 |
| Gross Margin | 46.5% |
| Operating Margin | 17.4% |
| Revenue Growth | 17.3% |
| Dividend Yield | 0.2% |
| Free Cash Flow | $-30M |
Shanghai United Imaging Healthcare Co., Ltd. operates in the Medical Devices industry, part of the Healthcare sector (China).